Author:
Maurer Marcus,Zuberbier Torsten,Metz Martin
Publisher
Springer International Publishing
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient-Reported Outcome Measures in Chronic Spontaneous Urticaria, Angioedema, and Atopic Dermatitis;The Journal of Allergy and Clinical Immunology: In Practice;2024-08
2. Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels;Dermatology and Therapy;2024-07-27
3. Disease modification in chronic spontaneous urticaria;Allergy;2024-07-24
4. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials;Journal of Allergy and Clinical Immunology;2024-07
5. A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm® in healthy Chinese subjects;Frontiers in Pharmacology;2024-05-17